Organizations such as the National Kidney Foundation, the American Kidney Fund, the National Institute of Diabetes and Digestive and Kidney Diseases, and the US Department of Health and Human Services recommend not including whole grains as part of the renal diet. The rationale for this recommendation is the high phosphorus content in these foods. While the phosphorus content in whole grains may be indeed high, it is covalently bound to organic molecules (primarily phytate) and requires the enzyme phytase to be released and become available for absorption. While some phytase is contained in some whole grains (corn, oats, and millet have little to no phytase activity), the enzyme is decreased in milling, food preparation and over time. Since the human intestine does not express phytase, the enzyme required for the release of phosphorus from phytate is not present in the intestinal lumen when ingesting cooked food. Consequently, the bioavailability of phosphorus from whole grains is low. For the reasons presented here we believe that the ‘grain ban' in the diet for kidney patients should be reconsidered. By doing this, the kidney diet would be enriched and it would provide needed fiber along with its health benefits, diversify the diet with low sodium choices, and possibly provide adequate protein without increasing phosphorous levels.

Keywords:
Phytase, Phytate, Renal diet, Whole grains
1.
Stevens LA, et al: Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 2004;15:770-779.
2.
Young EW, et al: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004;44(suppl 2):34-38.
3.
Block GA, et al: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
4.
National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):S1-S201.
5.
Kayne LH, et al: Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach. J Clin Invest 1993;91:915-922.
6.
Lei XG, Porres JM: Phytase enzymology, applications, and biotechnology. Biotechnol Lett 2003;25:1787-1794.
7.
Sullivan C, et al: Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009;301:629-635.
8.
Riccioni G, et al: Dietary fibers and cardiometabolic diseases. Int J Mol Sci 2012;13:1524-1540.
9.
Schlemmer U, Muller H, Jany KD: The degradation of phytic acid in legumes prepared by different methods. Eur J Clin Nutr 1995;49(suppl 3):S207-S210.
10.
Fredrikson M, et al: Phytate degradation by micro-organisms in synthetic media and pea flour. J Appl Microbiol 2002;93:197-204.
11.
Sandberg AS, Hulthen LR, Turk M: Dietary Aspergillus niger phytase increases iron absorption in humans. J Nutr 1996;126:476-480.
12.
Lopez HW, et al: Making bread with sourdough improves mineral bioavailability from reconstituted whole wheat flour in rats. Nutrition 2003;19:524-530.
13.
Bitar K, Reinhold JG: Phytase and alkaline phosphatase activities in intestinal mucosae of rat, chicken, calf, and man. Biochim Biophys Acta 1972;268:442-452.
14.
Irving GC, Cosgrove DJ: Inositol phosphate phosphatases of microbiological origin. Observations on the nature of the active centre of a bacterial (Pseudomonas sp.) phytase. Aust J Biol Sci 1971;24:559-564.
15.
Powar VK, Jagannathan V: Phytase from Bacillus subtilis. Indian J Biochem 1967;4:184-185.
16.
Schlemmer U, et al: Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. Mol Nutr Food Res 2009;53(suppl 2):S330-S375.
17.
Reddy NR, Sathe SK: Food phytates. Boca Raton, CRC Press, 2002, pp xv, 258.
18.
Graf E, Empson KL, Eaton JW: Phytic acid. A natural antioxidant. J Biol Chem 1987;262:11647-11650.
19.
Shamsuddin AM: Inositol phosphates have novel anticancer function. J Nutr 1995;125(suppl 3):725S-732S.
20.
Grases F, Costa-Bauza A: Phytate (IP6) is a powerful agent for preventing calcifications in biological fluids: usefulness in renal lithiasis treatment. Anticancer Res 1999;19:3717-3722.
21.
Thompson LU, Button CL, Jenkins DJ: Phytic acid and calcium affect the in vitro rate of navy bean starch digestion and blood glucose response in humans. Am J Clin Nutr 1987;46:467-473.
22.
Nilsson AC, et al: Effect of cereal test breakfasts differing in glycemic index and content of indigestible carbohydrates on daylong glucose tolerance in healthy subjects. Am J Clin Nutr 2008;87:645-654.
23.
Misra A, Rastogi K, Joshi SR: Whole grains and health: perspective for Asian Indians. J Assoc Physicians India 2009;57:155-162.
24.
Liu S, et al: Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999;70:412-419.
25.
Fung TT, et al: Whole-grain intake and the risk of type 2 diabetes: a prospective study in men. Am J Clin Nutr 2002;76:535-540.
26.
Liu S, et al: Relation between changes in intakes of dietary fiber and grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 2003;78:920-927.
27.
Jensen MK, et al: Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr 2004;80:1492-1499.
28.
Nettleton JA, et al: Incident heart failure is associated with lower whole-grain intake and greater high-fat dairy and egg intake in the Atherosclerosis Risk in Communities (ARIC) study. J Am Diet Assoc 2008;108:1881-1887.
29.
Flint HJ, et al: Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 2007;9:1101-1111.
30.
Louis P, et al: Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 2007;102:1197-1208.
31.
Nilsson AC, et al: Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. J Nutr 2008;138:732-739.
32.
Martinez I, et al: Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 2013;7:269-280.
33.
Gerrior S, Bente L, Center for Nutrition Policy and Promotion: Nutrient Content of the U.S. Food Supply, 1909-99: A Summary Report. Home Economics Research Report. 2002, Washington, Center for Nutrition Policy and Promotion, US Department. of Agriculture, pp i, 22.
34.
US Department of Agriculture Research Service. Data Tables: Results from USDA's 1994-96 Continuing Survey of Food Intakes by Individuals and 1994-96 Diet and Health Knowledge Survey. ARS Food Surveys Research Group, 1997. http://www.barc.usda.gov/bhnrc/foodsurvey/home.htm (accessed May 11, 2004).
35.
Norris J, Messina V: Vegan for Life: Everything You Need to Know to Be Healthy and Fit on a Plant-Based Diet. Cambridge, Da Capo Press, 2011, pp xix, 283.
36.
USDA National Database for standard Reference, Release 29. http://www.ars.usda.gov/nutrientdata (accessed December 2011).
37.
http://www.foodadditivies.org/phosphates/phosphates_used_in food.html.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.